Confluence Wealth Services’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$590K Buy
1,526
+180
+13% +$66.8K 0.02% 306
2026
Q1
$394K Sell
1,346
-41
-3% -$13.5K 0.02% 293
2025
Q4
$486K Buy
1,387
+62
+5% +$21K 0.02% 258
2025
Q3
$428K Hold
1,325
0.02% 270
2025
Q2
$515K Hold
1,325
0.03% 240
2025
Q1
$566K Buy
+1,325
New +$532K 0.04% 218
2022
Q1
Sell
-5
Closed -$2K 487
2021
Q4
$2K Buy
+5
New +$2.1K ﹤0.01% 1142

Other funds holding ELV

Confluence Wealth Services's ELV Position: Q2 2026 in Review

Confluence Wealth Services increased its Elevance Health (ELV) stake by 13% in Q2 2026, buying an estimated $66.8K and bringing the position to 1,526 shares worth $590K. The position accounts for 0.02% of the portfolio, ranked #306.

Confluence Wealth Services first reported a position in ELV in Q4 2021 and has held it in 7 quarters since. 1,601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Confluence Wealth Services held 1,526 shares of Elevance Health worth $590K as of Q2 2026.
  • Confluence Wealth Services bought 180 Elevance Health shares in Q2 2026, an estimated $66.8K.
  • Elevance Health made up 0.02% of Confluence Wealth Services's portfolio in Q2 2026, its #306 holding.
  • Confluence Wealth Services first reported a position in Elevance Health in Q4 2021 and has held it in 7 quarters since.
  • 1,601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Confluence Wealth Services's 13F filing for Q2 2026, filed 22 Jul 2026.